{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:44:03Z","timestamp":1794638643501,"version":"4.9.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s40121-023-00904-z","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T06:40:10Z","timestamp":1705560010000},"page":"207-220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Rates of Lower Respiratory Tract Illness in US Adults by Age and Comorbidity Profile"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5405-2215","authenticated-orcid":false,"given":"Derek","family":"Weycker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahuva","family":"Averin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnea","family":"Houde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ottino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Yacisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Curcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Begier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rozenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"issue":"1","key":"904_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/17476348.2019.1555040","volume":"13","author":"C Feldman","year":"2019","unstructured":"Feldman C, Shaddock E. Epidemiology of lower respiratory tract infections in adults. Expert Rev Respir Med. 2019;13(1):63\u201377.","journal-title":"Expert Rev Respir Med"},{"issue":"5","key":"904_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. New Engl J Med. 2015;373(5):415\u201327.","journal-title":"New Engl J Med."},{"issue":"5","key":"904_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/jgs.16327","volume":"68","author":"FW Arnold","year":"2020","unstructured":"Arnold FW, Reyes Vega AM, Salunkhe V, et al. Older adults hospitalized for pneumonia in the United States: incidence, epidemiology, and outcomes. J Am Geriatr Soc. 2020;68(5):1007\u201314.","journal-title":"J Am Geriatr Soc"},{"key":"904_CR4","volume-title":"Acute Bronchitis","author":"A Singh","year":"2023","unstructured":"Singh A, Avula A, Zahn E. Acute bronchitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448067\/."},{"issue":"1","key":"904_CR5","doi-asserted-by":"publisher","first-page":"ofv020","DOI":"10.1093\/ofid\/ofv020","volume":"2","author":"SI Pelton","year":"2015","unstructured":"Pelton SI, Shea KM, Weycker D, Farkouh RA, Strutton DR, Edelsberg J. Rethinking risk for pneumococcal disease in adults: the role of risk stacking. Open Forum Infect Dis. 2015;2(1):ofv020. https:\/\/doi.org\/10.1093\/ofid\/ofv020.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"904_CR6","doi-asserted-by":"publisher","first-page":"ofu024","DOI":"10.1093\/ofid\/ofu024","volume":"1","author":"KM Shea","year":"2014","unstructured":"Shea KM, Edelsberg J, Weycker D, Farkouh RA, Strutton DR, Pelton SI. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis. 2014;1(1):ofu024.","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"904_CR7","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/cid\/ciy800","volume":"68","author":"SI Pelton","year":"2019","unstructured":"Pelton SI, Bornheimer R, Doroff R, Shea KM, Sato R, Weycker D. Decline in pneumococcal disease attenuated in older adults and those with comorbidities following universal childhood PCV13 immunization. Clin Infect Dis. 2019;68(11):1831\u20138.","journal-title":"Clin Infect Dis"},{"issue":"39","key":"904_CR8","doi-asserted-by":"publisher","first-page":"6470","DOI":"10.1016\/j.vaccine.2010.07.037","volume":"28","author":"RK Zimmerman","year":"2010","unstructured":"Zimmerman RK, Lauderdale DS, Tan SM, Wagener DK. Prevalence of high-risk indications for influenza vaccine varies by age, race, and income. Vaccine. 2010;28(39):6470\u20137.","journal-title":"Vaccine"},{"issue":"3","key":"904_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/fampra\/cmi121","volume":"23","author":"E Hak","year":"2006","unstructured":"Hak E, Rovers M, Kuyvenhoven M, Schellevis F, Verheij T. Incidence of GP-diagnosed respiratory tract infections according to age, gender and high-risk co-morbidity: the Second Dutch National Survey of General Practice. Fam Pract. 2006;23(3):291\u20134.","journal-title":"Fam Pract"},{"key":"904_CR10","doi-asserted-by":"publisher","first-page":"04027","DOI":"10.7189\/jogh.11.04027","volume":"11","author":"R Kumar","year":"2021","unstructured":"Kumar R, Dar L, Amarchand R, et al. Incidence, risk factors, and viral etiology of community-acquired acute lower respiratory tract infection among older adults in rural north India. J Glob Health. 2021;11:04027\u201304027.","journal-title":"J Glob Health"},{"issue":"5","key":"904_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/dme.12384","volume":"31","author":"HI McDonald","year":"2014","unstructured":"McDonald HI, Nitsch D, Millett ERC, Sinclair A, Thomas SL. New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records. Diabet Med. 2014;31(5):606\u201314.","journal-title":"Diabet Med"},{"issue":"9","key":"904_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075131","volume":"8","author":"ERC Millett","year":"2013","unstructured":"Millett ERC, Quint JK, Smeeth L, Daniel RM, Thomas SL. Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study. PLoS\u00a0One. 2013;8(9): e75131.","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"904_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1186\/s12913-019-4412-7","volume":"19","author":"C Trucchi","year":"2019","unstructured":"Trucchi C, Paganino C, Orsi A, et al. Hospital and economic burden of influenza-like illness and lower respiratory tract infection in adults \u226550 years-old. BMC Health Serv Res. 2019;19(1):585.","journal-title":"BMC Health Serv Res"},{"key":"904_CR14","doi-asserted-by":"publisher","unstructured":"Lewnard JA, Bruxvoort KJ, Fischer H, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against medically-attended lower respiratory tract infection and pneumonia among older adults. Clin Infect Dis. 2022;75(5):832\u201341. https:\/\/doi.org\/10.1093\/cid\/ciab1051.","DOI":"10.1093\/cid\/ciab1051"},{"issue":"7","key":"904_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/ofid\/ofac300","volume":"9","author":"JM McLaughlin","year":"2022","unstructured":"McLaughlin JM, Khan F, Begier E, Swerdlow DL, Jodar L, Falsey AR. Rates of medically attended RSV among US adults: a systematic review and meta-analysis. Open Forum Infect Dis. 2022;9(7):300.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"904_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s40121-023-00758-5","volume":"12","author":"MH Rozenbaum","year":"2023","unstructured":"Rozenbaum MH, Judy J, Tran D, Yacisin K, Kurosky SK, Begier E. Low levels of RSV testing among adults hospitalized for lower respiratory tract infection in the United States. Infect Dis Ther. 2023;12(2):677\u201385.","journal-title":"Infect Dis Ther"},{"key":"904_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/M21-1550","volume":"175","author":"B-H Cho","year":"2022","unstructured":"Cho B-H, Weinbaum C, Tsai Y, Koppaka R. Influenza vaccine uptake and missed opportunities among the medicare-covered population with high-risk conditions during the 2018 to 2019 influenza season: a retrospective cohort study. Ann Intern Med. 2022;175(1):1\u201310. https:\/\/doi.org\/10.7326\/M21-1550.","journal-title":"Ann Intern Med"},{"issue":"3","key":"904_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3111\/13696998.2011.578188","volume":"14","author":"N Shi","year":"2011","unstructured":"Shi N, Palmer L, Chu B, et al. Association of RSV lower respiratory tract infection and subsequent healthcare use and costs: a Medicaid claims analysis in early-preterm, late-preterm, and full-term infants. J Med Econ. 2011;14(3):335\u201340.","journal-title":"J Med Econ"},{"issue":"29","key":"904_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.15585\/mmwr.mm7229a4","volume":"72","author":"M Melgar","year":"2023","unstructured":"Melgar M, Britton A, Roper LE, et al. Use of respiratory syncytial virus vaccines in older adults: recommendations of the advisory committee on immunization practices - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(29):793\u2013801.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"904_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/14760584.2021.1921579","volume":"20","author":"LR Grant","year":"2021","unstructured":"Grant LR, Slack MPE, Yan Q, et al. The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy. Expert Rev Vaccines. 2021;20(6):691\u2013705.","journal-title":"Expert Rev Vaccines"},{"key":"904_CR21","doi-asserted-by":"publisher","first-page":"106476","DOI":"10.1016\/j.rmed.2021.106476","volume":"185","author":"A Averin","year":"2021","unstructured":"Averin A, Shaff M, Weycker D, Lonshteyn A, Sato R, Pelton SI. Mortality and readmission in the year following hospitalization for pneumonia among US adults. Respir Med. 2021;185:106476. https:\/\/doi.org\/10.1016\/j.rmed.2021.106476.","journal-title":"Respir Med"},{"key":"904_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s41669-020-00240-9","volume":"5","author":"D Weycker","year":"2021","unstructured":"Weycker D, Moynahan A, Silvia A, Sato R. Attributable cost of adult hospitalized pneumonia beyond the acute phase. PharmacoEcon Open. 2021;5(2):275\u201384. https:\/\/doi.org\/10.1007\/s41669-020-00240-9.","journal-title":"PharmacoEcon Open"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-023-00904-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-023-00904-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-023-00904-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T08:18:14Z","timestamp":1706602694000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-023-00904-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1007\/s40121-023-00904-z","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Derek Weycker, Ahuva Averin, Linnea Houde, and Kevin Ottino are employees of PAI, which received funding from Pfizer for manuscript development. Kimberly Shea, Reiko Sato, Bradford D. Gessner, Kari Yacisin, Daniel Curcio, Elizabeth Begier, and Mark Rozenbaum are employed by, and hold shares of, Pfizer Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study database was de-identified prior to its release to study investigators, as set forth in the corresponding Data Use Agreement. Use of the study database for health services research was fully compliant with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and federal guidance on Public Welfare and the Protection of Human Subjects (45 CFR 46 \u00a746.101). Institutional Review Board approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}